Table 2

Pretreatment patient characteristics (intention to treat analysis) in the placebo, ranitidine 150 mg, omeprazole 10 mg (OM10), and omeprazole 20 mg (OM20) groups

  • 2-a All H pylori positivev all H pylorinegative patients.

  • 2-b Includes patients who recently stopped consumption.